收藏商品
全国免费服务热线
4000-520-616
Selectivefreefattyacidreceptor1(FFA1/GPR40)agonist.ExhibitsselectivityforGPR40overGPR41,GPR43,GPR119,GPR120andPPARγ.Inducesglucose-dependentinsulinsecretioninpancreaticMIN6cellsandinvivo.Enhancesinsulinsensitivityinatype2diabetesmodelinvivo.Orallyavailable.
AS2034178isalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight448.53.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Tanakaetal(2013)ChronictreatmentwithnovelGPR40agonistsimprovewhole-bodyglucosemetabolismbasedontheglucose-dependentinsulinsecretion.J.Pharmacol.Exp.Ther.346443PMID:23853170
Keywords:AS2034178,supplier,AS2034178,selective,free,fatty,acid,receptors,FFA1,GPR40,agonists,diabetes,insulin,sensitivity,FFAR1,Free,Fatty,Acid,Receptors,Free,Fatty,Acid,Receptors,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10